The document is an intimation regarding the availability of the audio recording of the Company's Earnings Conference Call for Q1 FY 2026-27 Results.
The earnings conference call was held on Thursday, August 06, 2026.
The disclosure is made pursuant to Regulation 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The audio recording of the Conference Call has been made available on the Company's website at the specific URL: https://ikshealth.com/ir/2027/q1/q1-earnings-call-recording.mp3
The letter is signed by Sameer Chavan, Company Secretary and Compliance Officer (Membership No. F7211) of Inventurus Knowledge Solutions Limited.
This communication is in continuation of an earlier letter dated July 31, 2026.
Additional Notes Section
The document serves as a compliance filing with the stock exchanges (BSE Limited and National Stock Exchange of India Limited) regarding investor communication.
No financial data, management commentary, strategic updates, or forward-looking statements were disclosed in this announcement.
The document explicitly states that no unpublished price sensitive information (UPSI) is being shared in this communication.
No attachments were mentioned as being included with this filing.
